Atlanta Braves Holdings, Inc. furnished an update on its business by announcing third-quarter results. The company reported that it issued a press release covering results of operations for the quarter ended September 30, 2025, which is included as Exhibit 99.1 to this Form 8-K.
The information under Item 2.02 and Exhibit 99.1 is being furnished, not filed, under the Exchange Act. The company’s Series A common stock trades as BATRA and Series C as BATRK on Nasdaq.
Atlanta Braves Holdings (BATRA) disclosed an insider transaction on a Form 4. A director reported an open‑market purchase (code P) of 840 shares of Series A Common Stock on 10/27/2025 at a weighted average price of $41.994, with trade prices ranging from $41.97 to $42.00.
Following the transaction, the reporting person beneficially owned 372,547 shares directly and 10,177 shares indirectly via the Leslie A. Malone 1995 Revocable Trust. The reporting person disclaims beneficial ownership of the indirectly held shares.
Atlanta Braves Holdings insider Jill L. Robinson, who is listed as EVP, CFO & Treasurer, executed two related transactions on 10/01/2025. She exercised a stock option to acquire 20,000 Series C common shares at an exercise price of $27.18, and on the same day sold 20,000 Series C common shares under a Rule 10b5-1 sales plan adopted May 15, 2025, at a weighted-average sale price of $40.998 (reported range $40.81–$41.18. After the transactions the filings show 68,755 Series C shares owned directly and 130,263 total Series C shares beneficially owned as reported in the derivative table.
Insider sale notice for Atlanta Braves Holdings, Inc. (BATRA) — A Rule 144 notice reports a proposed sale of 20,000 Series C common shares through UBS Financial Services on NASDAQ with an aggregate market value of $820,000. The filer states these shares were acquired on 10/01/2025 by exercise of stock options and paid in cash the same day. The filing also discloses a sale by Jill Robinson of 40,000 Series C shares on 08/15/2025 that generated $1,752,950 in gross proceeds. The filing includes the total number of Series C shares outstanding as 51,459,265 and contains the statutory signature and certification language required under Rule 144.
Reporting persons including GAMCO Investors, Associated Capital Group, GGCP Inc., and Mario J. Gabelli disclosed multiple sales of Atlanta Braves Holdings, Inc. Series A common stock in mid-September 2025. Reported transactions include an 800-share sale on 09/18/2025 at $45.4888 and a 1,100-share sale on 09/19/2025 at $45.1945, plus additional dispositions or indirect ownership adjustments totaling at least 98,452 shares across several entries. Post-transaction beneficial ownership amounts shown include 2,900 shares and 1,800 shares for specific entries, with other blocks held indirectly by named investment partnerships and entities. The filings note disgorgement payments to the issuer for the two sales and explain that reported beneficial ownership reflects total holdings of entities exceeding the reporting persons' direct pecuniary interests.
Gregory John Heller, EVP, CLO & Secretary of Atlanta Braves Holdings, Inc. (BATRK), exercised options and sold shares on 08/21/2025. He exercised a stock option with a $27.18 exercise price to acquire 60,000 shares of Series C common stock and immediately sold 60,000 shares at a weighted average sale price of $43.45, with the sale price range reported as $43.09 to $43.70. After these transactions he beneficially owned 14,876 shares of Series C common stock directly and 80,263 shares through previously held derivative securities or other holdings.
The Form 4 was signed by an attorney-in-fact on 08/22/2025 and discloses the option grant’s original grant date (12/10/2023) and option expiration date (12/10/2027). The filing notes the reported sale price is a weighted average and that detailed per-price sale breakdowns are available upon regulatory request.
Atlanta Braves Holdings, Inc. (BATRK) filed a Form 144 notifying the proposed sale of 60,000 Series C common shares through UBS Financial Services on 08/21/2025 with an aggregate market value of $2,613,000. The shares were acquired the same day via a stock option exercise from Atlanta Braves Holdings, Inc., and payment was recorded on 08/21/2025. There were no securities sold by this person in the past three months. The filing represents a routine insider disposition reported under Rule 144 to comply with securities-sale reporting requirements.
Jill L. Robinson, EVP, CFO & Treasurer of Atlanta Braves Holdings, Inc. (BATRK), reported transactions dated 08/15/2025. She exercised a stock option to acquire 40,000 Series C shares at an exercise price of $27.18, which increased her reported beneficial ownership to 108,755 shares. On the same date she sold 40,000 Series C shares under a Rule 10b5-1 sales plan adopted May 15, 2025, at a weighted average sale price of $43.82 (range $43.68 to $44.12), leaving 68,755 Series C shares beneficially owned after the sale. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Atlanta Braves Holdings, Inc. (BATRK) reported a Rule 144 notice for the proposed sale of 40,000 shares of Series C common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $1,760,800.00. The filing shows the same 40,000 shares were acquired and paid for on 08/15/2025 by exercise of stock options and paid in cash, and no sales by the reporting person were reported in the prior three months.
The notice includes the standard representation that the seller does not possess undisclosed material adverse information. Outstanding shares are listed as 51,459,265, which provides context for the size of the transaction versus the company’s share base.